The initial investment, which will allow the company to make revolutionary, cottony-soft hygiene products for the North American market, is scheduled to be comple in mid-2021.
“We are the first to invest in the latest R5 machinery in the US. This commitment, in combination with our unique proprietary technology, allows us to produce consumer-preferred ultra-high loft, soft and textured nonwoven fabrics. This solidifies PFN’s position as a global leader in the production of innovative spunmelt nonwoven fabrics,” says Shane Vincent, chief commercial officer & global head of business development.
PFN’s chief technology and product development officer, Tonny de Beer, highlighted that “PFN has always been a pioneer of the latest technology. These investments allow us to continue our leadership in the commercialization of innovative hygiene and medical nonwovens, and pave new ways to improve sustainability and reduce environmental impact.”
Phase two of the expansion, which will involve a second new production line, is scheduled to be complete in 2022. The company has not yet revealed details on this new line. It will be the eighth nonwoven line located in PFNonwovens Halzleton, PA site, which it acquired from First Quality Nonwovens in 2018. Earlier this year PFNonwovens divested a nonwovens plant in Wuxi, China, which was also acquired from First Quality.
